Renata Medical is a leading pediatric cardiovascular device company dedicated to transforming care for children with congenital heart disease. Headquartered in California and founded in 2019, Renata Medical designs, develops, and manufactures technology purposefully created for unmet pediatric needs. Its flagship product, the Minima Stent System, is designed, tested, and FDA approved for treating vascular stenosis in neonates and infants, and is engineered to be gradually re-expanded to adult sizes as a child grows. Minima received FDA premarket approval in August 2024 and has since been commercially available, with strong adoption.